These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3378854)

  • 1. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
    Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R
    Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis.
    Merkel C; Bianco S; Bolognesi M; Caregaro L; Amodio P; Sacerdoti D; Gatta A
    Am J Gastroenterol; 1992 Nov; 87(11):1580-6. PubMed ID: 1442677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
    Merkel C; Gatta A; Caregaro L; Sacerdoti D; Rondana M; Ruol A
    Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic function and portal hemodynamics in patients with liver cirrhosis.
    Kawasaki T; Moriyasu F; Kimura T; Someda H; Tamada T; Yamashita Y; Ono S; Kajimura K; Hamato N; Okuma M
    Am J Gastroenterol; 1990 Sep; 85(9):1160-4. PubMed ID: 2202201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis.
    Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Chen KY; Chiang BN; Lo KJ
    Hepatogastroenterology; 1988 Jun; 35(3):121-4. PubMed ID: 3402902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
    Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
    Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
    Tietge UJ; Böker KH; Manns MP; Bahr MJ
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M; Watanabe G
    J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M; Watanabe G
    Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
    Ott P; Keiding S; Bass L
    Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation.
    Tietge UJ; Bahr MJ; Manns MP; Böker KH
    Liver Transpl; 2001 Dec; 7(12):1015-22. PubMed ID: 11753903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of dichloroacetate in patients with cirrhosis.
    Shangraw RE; Fisher DM
    Clin Pharmacol Ther; 1999 Oct; 66(4):380-90. PubMed ID: 10546922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of hepatic blood flow in chronic liver diseases using the constant infusion technic].
    Vorobioff J; Carnovale C; Topol R; Picabea E; Villavicencio R; Tanno H; Audano M; Audano G
    Acta Gastroenterol Latinoam; 1984; 14(3):229-34. PubMed ID: 6537116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
    Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
    Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
    Hamberg O
    Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic plasma flow estimated according to Fick's principle in patients with hepatic encephalopathy: evaluation of indocyanine green and D-sorbitol as test substances.
    Clemmesen JO; Tygstrup N; Ott P
    Hepatology; 1998 Mar; 27(3):666-73. PubMed ID: 9500692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyrine clearance and its correlation to routine liver function tests in patients with liver disease.
    Krausz Y; Zylber-Katz E; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):253-7. PubMed ID: 7450926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.